The Cooper Companies (COO) reported $1.06 billion in revenue for the quarter ended July 2025, representing a year-over-year increase of 5.7%. EPS of $1.10 for the same period compares to $0.96 a year ago.
The reported revenue represents a surprise of -0.5% over the Zacks Consensus Estimate of $1.07 billion. With the consensus EPS estimate being $1.07, the EPS surprise was +2.8%.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how The Cooper Companies performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Revenue by Geography- Americas: $286 million compared to the $311.49 million average estimate based on two analysts. The reported number represents a change of +2.2% year over year.
- Revenue by Geography- Asia Pacific: $140.3 million versus the two-analyst average estimate of $143.68 million. The reported number represents a year-over-year change of +0.7%.
- Revenue by Geography- EMEA: $292.1 million versus the two-analyst average estimate of $267.71 million. The reported number represents a year-over-year change of +13.9%.
- Revenue by Category- CVI: $718.4 million versus the six-analyst average estimate of $723.97 million. The reported number represents a year-over-year change of +6.3%.
- Revenue by Category- CSI: $341.9 million versus $343.37 million estimated by six analysts on average. Compared to the year-ago quarter, this number represents a +4.5% change.
- Revenue by Category- CSI- Office and surgical: $204.8 million versus the five-analyst average estimate of $209.17 million. The reported number represents a year-over-year change of +3.5%.
- Revenue by Category- CSI- Fertility: $137.1 million compared to the $134.62 million average estimate based on five analysts. The reported number represents a change of +6% year over year.
- Revenue by Category- CVI- Sphere, other: $359.6 million compared to the $371 million average estimate based on five analysts. The reported number represents a change of +3% year over year.
- Revenue by Category- CVI- Toric and multifocal: $358.8 million versus the five-analyst average estimate of $352.82 million. The reported number represents a year-over-year change of +9.9%.
View all Key Company Metrics for The Cooper Companies here>>>
Shares of The Cooper Companies have returned -0.1% over the past month versus the Zacks S&P 500 composite's +1.3% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
The Cooper Companies, Inc. (COO): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
